Taurine supplementation reduces oxidative stress and protects the liver in an iron-overload murine model

Molecular Medicine Reports

Volumn 10, Issue 5, 2014, Pages 2255-2262

  Zhang, Zeyu ^a   Liu, Dan ^a   Yi, Bo ^b   Liao, Zhangping ^a   Tang, Lei ^a   Yin, Dong ^a   He, Ming ^a  

^a NANCHANG UNIVERSITY   (China)

^b Jiangxi Province Tumor Hospital   (China)

Author keywords

Apoptosis; Iron overload; Liver; Oxidative stress; Taurine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; IRON; REACTIVE OXYGEN METABOLITE; TAURINE; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATTENUATION; CONTROLLED STUDY; ENZYME ACTIVITY; IRON OVERLOAD; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIVER CELL; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER PROTECTION; LIVER TOXICITY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; MOUSE; NONHUMAN; OXIDATIVE STRESS; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; LIVER; LIVER MITOCHONDRION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

MURINAE; MUS;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; CATALASE; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; HEPATOCYTES; IRON OVERLOAD; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA, LIVER; MITOCHONDRIAL SWELLING; OXIDATIVE STRESS; PROTECTIVE AGENTS; TAURINE;

EID: 84907226913     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2544     Document Type: Article

References (49)

1. Santos PC, Krieger JE and Pereira AC: Molecular diagnostic and pathogenesis of hereditary hemochromatosis. Int J Mol Sci 13: 1497-1511, 2012.
2. Murphy CJ and Oudit GY: Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment. J Card Fail 16: 888-900, 2010.
3. Moretti D, van Doorn GM, Swinkels DW and Melse-Boonstra A: Relevance of dietary iron intake and bioavailability in the management of HFE hemochromatosis: a systematic review. Am J Clin Nutr 98: 468-479, 2013.
4. Alústiza Echeverría JM, Castiella A and Emparanza JI: Quantification of iron concentration in the liver by MRI. Insights Imaging 3: 173-180, 2012.
5. Lee M and Kowdley KV: Alcohol's effect on other chronic liver diseases. Clin Liver Dis 16: 827-837, 2012.
6. Hayashi H, Piperno A, Tomosugi N, et al: Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosis. Intern Med 49: 2371-2377, 2010.
7. Abdalla MY, Fawzi M, Al-Maloul SR, El-Banna N, Tayyem RF and Ahmad IM: Increased oxidative stress and iron overload in Jordanian β -thalassemic children. Hemoglobin 35: 67-79, 2011.
8. Li X, Li H, Lu N, Feng Y, Huang Y and Gao Z: Iron increases liver injury through oxidative/nitrative stress in diabetic rats: Involvement of nitrotyrosination of glucokinase. Biochimie 94: 2620-2627, 2012.
9. Serviddio G, Bellanti F, Sastre J, Vendemiale G and Altomare E: Targeting mitochondria: a new promising approach for the treatment of liver diseases. Curr Med Chem 17: 2325-2337, 2010.
10. Liu D, He H, Yin D, Que A, Tang L, Liao Z, Huang Q and He M: Mechanism of chronic dietary iron overload-induced liver damage in mice. Mol Med Rep 7: 1173-1179, 2013.
11. Batista TM, Ribeiro RA, da Silva PM, Camargo RL, Lollo PC, Boschero AC and Carneiro EM: Taurine supplementation improves liver glucose control in normal protein and malnourished mice fed a high-fat diet. Mol Nutr Food Res 57: 423-434, 2013.
12. Heidari R, Babaei H and Eghbal MA: Cytoprotective effects of taurine against toxicity induced by isoniazid and hydrazine in isolated rat hepatocytes. Arh Hig Rada Toksikol 64: 15-24, 2013.
13. Hartman JC, Brouwer K, Mandagere A, Melvin L and Gorczynski R: Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. Can J Physiol Pharmacol 88: 682-691, 2010.
14. Liao Y, Lu X, Lu C, Li G, Jin Y and Tang H: Selection of agents for prevention of cisplatin-induced hepatotoxicity. Pharmacol Res 57: 125-131, 2008.
15. Tabassum H, Rehman H, Banerjee BD, Raisuddin S and Parvez S: Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin Chim Acta 370: 129-136, 2006.
16. Wang GG, Li W, Lu XH, Zhao X and Xu L: Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. Croat Med J 54: 171-179, 2013.
17. Higuchi M, Celino FT, Shimizu-Yamaguchi S, Miura C and Miura T: Taurine plays an important role in the protection of spermatogonia from oxidative stress. Amino Acids 43: 2359-2369, 2012.
18. Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP and Backx PH: L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9: 1187-1194, 2003.
19. Galleano M and Puntarulo S: Hepatic chemiluminescence and lipid peroxidation in mild iron overload. Toxicology 76: 27-38, 1992.
20. Keith ME, Ball A, Jeejeebhoy KN, Kurian R, Butany J, Dawood F, Wen WH, Madapallimattam A and Sole MJ: Conditioned nutritional deficiencies in the cardiomyopathic hamster heart. Can J Cardiol 17: 449-458, 2001.
21. Okhawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979.
22. Beauchamp C and Fridovich I: Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44: 276-287, 1971.
23. Hill MF and Singal PK: Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96: 2414-2420, 1997.
24. Anderson ME: Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113: 548-555, 1985.
25. Kalantari-Dehaghi M, Chen Y, Deng W, Chernyavsky A, Marchenko S, Wang PH and Grando SA: Mechanisms of mitochondrial damage in keratinocytes by Pemphigus vulgaris antibodies. J Biol Chem 288: 16916-16925, 2013
26. Beavis AD, Brannan RD and Garlid KD: Swelling and contraction of the mitochondrial matrix. I. A structural interpretation of the relationship between light scattering and matrix volume. J Biol Chem 260: 13424-13433, 1985.
27. Misra HP and Fridovich I: The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247: 3170-3175, 1972.
28. Ketterer B: Detoxication reactions of glutathione and glutathione transferases. Xenobiotica 16: 957-973, 1986.
29. Liu CM, Zheng GH, Ming QL, Sun JM and Cheng C: Protective effect of quercetin on lead-induced oxidative stress and endoplasmic reticulum stress in rat liver via the IRE1/JNK and PI3K/Akt pathway. Free Radic Res 47: 192-201, 2013.
30. Banu S, Bhaskar B and Balasekar P: Hepatoprotective and antioxidant activity of Leucas aspera against D-galactosamine induced liver damage in rats. Pharm Biol 50: 1592-1595, 2012.
31. Pompella A, Visvikis A, Paolicchi A, De Tata V and Casini AF: The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66: 1499-1503, 2003.
32. Schaffer SW, Azuma J and Mozaffari M: Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87: 91-99, 2009.
33. Pardo Andreu GL, Inada NM, Vercesi AE and Curti C: Uncoupling and oxidative stress in liver mitochondria isolated from rats with acute iron overload.Arch Toxicol 83: 47-53, 2009.
34. Tirnitz-Parker JE, Glanfield A, Olynyk JK and Ramm GA: Iron and hepatic carcinogenesis. Crit Rev Oncog 18: 391-407, 2013.
35. Sorrentino P, Terracciano L, D'Angelo S, et al: Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis. J Gastroenterol 45: 1053-1062, 2010.
36. Lalisang TJ: Serum bile acid: an alternative liver function marker in the obstructive jaundice patient. Acta Med Indones 44: 233-238, 2012.
37. Manna P, Sinha M and Sil PC: Taurine plays a beneficial role against cadmium-induced oxidative renal dysfunction. Amino Acids 36: 417-428, 2009.
38. Sinha M, Manna P and Sil PC: Taurine, a conditionally essential amino acid, ameliorates arsenic-induced cytotoxicity in murine hepatocytes. Toxicol In Vitro 21: 1419-1428, 2007.
39. Aruoma OI, Halliwell B, Hoey BM and Butler J: The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256: 251-255, 1988.
40. Budhram R, Pandya KG and Lau-Cam CA: Protection by taurine and thiotaurine against biochemical and cellular alterations induced by diabetes in a rat model. Adv Exp Med Biol 775: 321-343, 2013.
41. Kang IS and Kim C: Taurine chloramine administered in vivo increases NRF2-regulated antioxidant enzyme expression in murine peritoneal macrophages. Adv Exp Med Biol 775: 259-267, 2013.
42. Ghyasi R, Sepehri G, Mohammadi M, Badalzadeh R and Ghyasi A: Effect of mebudipine on oxidative stress and lipid peroxidation in myocardial ischemic-reperfusion injury in male rat. J Res Med Sci 17:1150-1155, 2012.
43. Ramesh B, Karuna R, Sreenivasa RS, Haritha K, Sai MD, Sasi BR and Saralakumari D: Effect of Commiphora mukul gum resin on hepatic marker enzymes, lipid peroxidation and antioxidants status in pancreas and heart of streptozotocin induced diabetic rats. Asian Pac J Trop Biomed 2: 895-900, 2012.
44. Huxtable RJ: Physiological actions of taurine. Physiol Rev 72: 101-163, 1992.
45. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K and Rhee SG: Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300: 653-656, 2003.
46. Sharma V, Anderson D and Dhawan A: Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis 17: 852-870, 2012.
47. Zhao CY, Liu XY and Shen C: Molecular mechanisms of mitochondrial damage in the development of liver failure. Zhonghua Gan Zang Bing Za Zhi 19: 955-957, 2011 (In Chinese).
48. Gottlieb RA and Gustafsson AB: Mitochondrial turnover in the heart. Biochim Biophys Acta 1813: 1295-1301, 2011.
49. Bae YS, Oh H, Rhee SG and Yoo YD: Regulation of reactive oxygen species generation in cell signaling. Mol Cells 32: 491-509, 2011.